eCommons@AKU
Section of Gastroenterology

Department of Medicine

June 2015

Hepatic encephalopathy in chronic liver disease:
predisposing factors in a developing country
Fakhar Qazi
Aga Khan University, fakhar.qazi@aku.edu

Shameem Behram Khan
Jinnah Post Graduate Medical Centre

Anam Umar
Jinnah Post Graduate Medical Centre, Karachi

Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_med_gastroenterol
Part of the Gastroenterology Commons
Recommended Citation
Qazi, F., Khan, S. B., Umar, A. (2015). Hepatic encephalopathy in chronic liver disease: predisposing factors in a developing country.
Asian Journal of Medical Sciences, 6(2), 35-42.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_med_gastroenterol/89

O R I G I N A L A RTICL E

ASIAN JOURNAL OF MEDICAL SCIENCES

Hepatic encephalopathy in chronic liver disease;
predisposing factors in a developing country
Fakhar Ali Qazi Arisar1, Shameem Behram Khan2, Anam Umar2
1
Department of Medicine, Section of Gastroenterology, Aga Khan University Hospital, Karachi, Sindh, Pakistan, 2Department of Medicine,
Ward-5, Jinnah Post Graduate Medical Centre, Karachi, Sindh, Pakistan

Submitted: 28-06-2014

Revised: 24-08-2014

Published: 31-10-2014

ABSTRACT
Objective: To find out the risk factors for developing Hepatic Encephalopathy in patients
suffering from Chronic liver disease. Background: Hepatic encephalopathy (HE) is a
neuropsychiatric disorder that is caused by liver damage. In its pathology, alterations in
normal brain function are associated with an increase in blood ammonia, benzodiazepine like
substances, products of neurotoxic fatty acids, and other gut derived toxins, which gain
access to the brain as a result of liver dysfunction. Study Design: Hospital based descriptive,
cross sectional study. Settings: Medical Unit 1, Ward- 5, Jinnah Post Graduate Medical
Centre, Karachi. Duration: July 2013 to December 2013. Patients and Methods: About
150 patients admitted in medical unit 1 with a diagnosis of chronic liver disease in a state of
hepatic encephalopathy were included in this study. Patients suffering from viral or bacterial
encephalitis, stroke, brain tumor, Wernicke’s encephalopathy were excluded from the study.
Results and Observations: There were 96 (64%) female and 54 (36%) were male patients.
Mean age of the patients was 52.45 (±12.271) years. 80 (53.33%) patients were having
constipation. Infection was found in 55 (36.66%) cases. Upper GI Bleed was present in
51 (34%) patients. 44 (29.33%) patients had moderate to severe electrolyte imbalance as
the cause. Constipation alone was the cause in 11.33% of cases. More than one factor
was found to be responsible in around 56% of patients while in 6.6% of cases none of
these precipitating factors was isolated. Conclusion: Constipation is the commonest cause
of hepatic encephalopathy followed by infection, upper GI bleed and electrolyte imbalance.
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INTRODUCTION
Chronic liver disease is a worldwide major problem and
alcohol is the leading cause of chronic liver disease in
western societies, while hepatitis B and C viruses are the
major in Pakistan. The prevalence of hepatitis B is over
10% in the Asia-pacific region where as the prevalence of
chronic hepatitis C in the Asia-pacific region is variable
between 4 to 12%.1,2
It causes significant morbidity and mortality, mainly due
to complications like hepatic encephalopathy, ascites,
hepatorenal syndrome (HRS) and esophageal variceal
hemorrhage (EVH). 3 Hepatic encephalopathy (HE)
is present in up to 70% of all patients with cirrhosis,

including patients with abnormalities demonstrable only by
psychometric testing,4,5 out of which about 30% patients
of chronic liver disease die of hepatic encephalopathy.6,7
Hepatic encephalopathy describes a range of neuropsychiatric
oddities that occur as a result of liver failure. The most
primitive known paper to date on HE is by Giovanni
Battista Morgagni in eighteenth century. Morgagni’s book
of medicine reported the case of a man with liver cirrhosis
who had coma and subsequently died, whose gross brain
examination did not show any alteration (Morgagni 1765).8
Many ideas generated and struggles are made to find out
the exact pathophysiology of H.E. The diversion of portal
blood into the systemic circulation through Porto systemic
collateral vessels is found to be an imperative requirement
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for the syndrome. It accompanies portal-systemic shunting
of venous blood that occurs either spontaneously, due to
cirrhosis, or non-cirrhotic portal hypertension, or surgically
following porto-caval anastomosis surgery or trans-jugular
intra-hepatic porto-systemic shunt (TIPS) aimed at relieving
portal hypertension.9

Jinnah Postgraduate Medical Centre, Karachi, from July
2013 to December 2013. 150 consecutive patients of
Chronic Liver Disease diagnosed previously or newly
diagnosed after admission, between the ages of 14 to
83 years, presenting with encephalopathy were enrolled
in the study.

A relationship between portal-systemic shunting of blood
and behavioral alterations, including coma, was clearly
proven in porto-caval shunted dogs (i.e., submitted to
Eck fistula) by Hahn et al. (1893)10 who demonstrated that
meat-rich meals could cause ‘encephalitis’.

Data collection

Many studies also emphasize the role of neurotoxic agents
in H.E. Van Caulet in 193211 declared that Ammonia is the
principal neurotoxin in instigating coma and disturbed brain
function in patients of cirrhosis, the same was then proven by
Sthal in 1936.12 Although many critic focused strictly on the
involvement of neurotoxins and it remained controversial for
a long period of time but now it is widely accepted that they
have a certain role in the pathogenesis of H.E and among
them ammonia is the toxin of interest. Ammonia formed
by the colonic bacteria is carried to the liver via portal vein
after absorption, where it is incorporated in the urea cycle
for detoxification. Other gut-derived toxins have also been
proposed e.g. benzodiazepine like substances, products
of colonic bacterial metabolism such as neurotoxic short
and medium chain fatty acids, phenols and mercaptans and
manganese. Ammonia and the other substances gain access
to the systemic circulation as a result of decreased hepatic
function or porto-systemic shunts and harmfully disturbs
brain function and theaters a role in the pathogenesis of
H. E. In the brain these compounds produce alterations
of neurotransmission that affect cognizance and behavior.
Abnormalities in glutamatergic, serotoninergic, gaminobutyric
acid-ergic (GABA-ergic) and catecholamine pathways have
been described in experimental hepatic encephalopathy. The
role of ammonia in hepatic encephalopathy is supported by
the finding of high arterial ammonia level. The permeability
of blood-brain barrier for ammonia is increased in patients
with hepatic encephalopathy. Furthermore, ammonia after
entering into the astrocytes, is metabolized and leads to
changes in neurotransmission and hence alters the cellular
functions. Manganese is deposited in basal ganglia and
induces extra pyramidal symptomatology. It’s also been
proposed that an alteration in the ratio of branch chain
amino acids and aliphatic amino acids can also predisposes
to hepatic encephalopathy.13

PATIENTS AND PROCEDURES
Study design and setting

It was a hospital based descriptive, cross sectional
study, carried out at department of medicine, ward 5,
36

A Performa was structured and check list was used for
data collection. Detailed history was obtained with special
consideration to fever, GI bleed, Burning micturition,
Diarrhea, vomiting, constipation, abdominal pain and
distension, jaundice, diet and drugs like sedatives, diuretics
and cough syrups. Patients were examined with special
attention to fever, anemia, jaundice, palmar erythema,
spider nevi, gynaecomastia, asterixis, dehydration, edema,
splenomegaly and ascites. Relevant hematological,
biochemical and radiological investigations were ordered
including complete blood count, urea, creatinine and
electrolytes, liver function tests, coagulation profile, serum
proteins, serum albumin and globulin ratio, HBsAg, Anti
HCV Antibody, urine D/R, ascitic fluid D/R, serum
ammonia, chest X-Ray, ultrasound abdomen, CT Brain
and upper GI endoscopy. All patients underwent standard
management during their hospital stay which included use
of lactulose, metronidazole, 3rd generation cephalosporin,
proton pump inhibitor, and vitamin K and FFP in patient
with deranged coagulation profile or GI bleed. Ryle’s tube
for feeding purposes was placed in patients with hepatic
encephalopathy grade > 2. Outcomes assessed were the
discharge or death during admission period.
Inclusion criteria

Cirrhosis was diagnosed on the basis of clinical signs &
symptoms, laboratory findings (deranged coagulation profile
and reversal of albumin/globulin ratio) and ultrasound
findings (size and echogenicity of liver, portal vein diameter,
splenomegaly), and patients were categorized according to
Child Pugh classification (Table 1). Diagnosis of hepatic
encephalopathy was made on the basis of history, physical
examination and number connection test, and was graded
from I to IV according to the West Haven criteria (Table 2).
Exclusion criteria

Patients suffering from acute liver failure, non cirrhotic
portal hypertension, intracranial lesions such as subdural
Table 1: Child pugh classification
Bilirubin (mg/dl)
Serum Albumin (g/dl)
Grade of Encephalopathy
Grade of Ascites
INR

1

2

3

<2
>3.5
None
None
<1.2

2-3
2.8-3.5
Mild
Mild
1.2-1.7

>3
<2.8
Moderate to severe
Moderate to severe
>1.7

Child A: 5-6, Child B: 7-9, Child C: 10-15
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hematoma, cerebral infarction or bleed, meningitis,
encephalitis, brain abscess, hypoxia, hypercarbia,
ketoacidosis, neuropsychiatric disorders or post-epileptic
confusion were excluded from the study.
Operational definitions

Constipation was defined as failure to pass stool in
48 hours, infection as presence of fever, raised leukocyte
count, significant pyuria (at greater than or equal to
10 leucocytes/mm3), >500 TLC or >250 neutrophils in
ascitic D/R, electrolyte imbalance as high or low level of
serum sodium or serum potassium as per the reference levels,
upper gastrointestinal bleed as history of hematemesis or
melena, dehydration as presence of dry tongue and loss of
skin turgor, high protein diet as recent unrestricted high
intake of proteins consumed in any form, renal impairment
as creatinine of >2.

The most common cause of chronic liver disease was found
to be HCV in our patients. Frequency of viral hepatitis as
a cause of chronic liver disease is mentioned in Figure 3.
Out of 150 admitted patients, 107 (71.3%) were discharged,
while 43 (28.7%) passed away. The frequency of grade of
hepatic encephalopathy in our patients is shown in Figure 4.
Male

Female

54
36%

96
64%

Data analysis

Statistical analysis was done using SPSS version 19 and
the results were obtained in the terms of frequencies and
percentages for descriptive analysis. Chi-Square and student
t tests were used to analyze the numerical data and p value
of <0.05 was considered statistically significant.

Figure 1: Gender distribution of patients included in the study

72

RESULTS
A total number of one hundred and fifty (n = 150)
adults diagnosed cases of chronic liver disease who
presented with hepatic encephalopathy irrespective of
cause were included, out of them ninety six (n = 96,
64%) were females and fifty four (n = 54, 36%) were
males. Majority (n = 106, 70%) of the patients in our
study belong from middle age group (i.e., 40-60 years
of age), with mean age of 52.45 (±12.271) years. The
age and gender distribution of the patients is shown in
Figure 1 & 2.
Table 2: West haven criteria
Grade 1

Grade 2

Grade 3
Grade 4

Mild confusion
Trivial lack of awareness
Euphoria or anxiety
Shortened attention span
Impaired performance of addition
Drowsiness
Lethargy or apathy
Minimal disorientation for time or place
Subtle personality change
Inappropriate behavior
Impaired performance of subtraction
Somnolence but arousable
Marked confusion
Gross disorientation
Coma
(unresponsive to verbal or noxious stimuli)
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12
2
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Figure 2: Age frequency of the patients enrolled in the study

3, 3,
2% 2%
11,
7%
Non-B, Non-C
HCV
HBV
Both HBV and HCV
133,
89%
.
Figure 3: Frequency of vital hepatitis as a cause of chronic liver disease
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Sign & symptoms (in the decreasing order of frequency)
and the laboratory parameters of our patients are
mentioned in the Figure 5 and Table 3.
TLC count was low in 13 (8.66%), normal in 94 (62.66%)
and high in 43 (28.66%) of our patients. Urea was
deranged in 78 (52%), while creatinine was high in
20 (13.33%) of the cases. Hypoalbuminema was recorded
in 118 (78.66%), while deranged coagulation profile was
found in 85 (56.66%) of subjects. Fifty one (51) patients
in our study presented with GI Bleed comprising of 34%
of total cases.
Out of 150 patients, 07 (4.6%) had hypernatremia while
62 (41.33%) had normal sodium level. Hyponatremia
was present in 81 (54%) patients. Of those having
hyponatremia, 51 patients fall in the category of mild,
Table 3: Laboratory parameters of all patients
with hepatic encephalopathy
Minimum Maximum Mean
Hemoglobin (mg/dl)
TLC (x109/L)
Neutrophils (% of WBC)
Platelets
RBS (mg/dl)
Urea (mg/dl)
Creatinine (mg/dl)
Serum Sodium (meq/l)
Serum Potassium (meq/l)
Serum Chloride (meq/l)
Total Bilirubin (mg/dl)
ALT (u/l)
AST (u/l)
Serum Albumin (mg/dl)
A/G ratio
PT (sec)
INR
Serum Ammonia (μg/dl)
Liver span (cm)
Portal vein diameter
Spleen size

116
77%

1.7
1.8
5
15
61
15
0.10
83.0
1.70
81.0
0.60
12
22
1.6
0.4
13.0
1.00
31
7.3
0.7
8.8

92
61%

13.2
33.0
94
388
591
201
5.20
153.0
5.94
127.8
26.00
113
304
33.0
1.2
38.6
4.10
388
14.6
2.0
18.9

80
53%

8.417
9.291
75.04
96.19
149.63
61.56
1.3939
131.840
3.8703
102.518
4.3302
37.34
80.02
3.574
0.816
20.171
1.5506
191.29
11.115
1.19
13.43

79
52%

Std.
deviation
2.1582
5.9084
18.562
63.906
88.079
46.069
0.97563
10.1431
0.96595
9.1711
4.93379
20.899
60.401
4.0016
0.1536
6.5844
0.63901
94.566
1.9717
0.3210
2.1089

63
42%

51
34%

23 in moderate and 7 had severely low serum sodium.
Similarly, out of total 150 patients 07 (4.6%) had
hyperkalemia while 92 (61.33%) had normal potassium
level. Hypokaelmia was present in 51 (34%) patients. Of
those having hypokalemia, 42 patients fall in the category
of mild, and 9 had moderately low serum potassium.
Frequency of infections and electrolyte imbalances is
mentioned in the Table 4.
Eighty (53.33%) patients were having constipation.
Infection was found in 55 (36.66%) cases. Upper GI
Bleed was present in 51 (34%) patients. 44 (29.33%)
patients had moderate to severe electrolyte imbalance as
the cause. Constipation alone was the cause in 11.33% of
cases. More than one factor was found to be responsible
in around 56% of patients while in 6.6% of cases none
of these precipitating factors was isolated.
Grade of hepatic encephalopathy in our patients was
directly related with the number of predisposing factors
as shown in Table 5.
Grade – I

Grade – II

Grade – III

Grade – IV

8
5%
52

44

35%

29%

46
31%

Figure 4: Classification of patients according to the grades of
encephalopathy

39
26%

33
22%

27
18%

21
14%

19
12%

19
12%

12
8%

Figure 5: Sign and symptoms of the patients included in the study
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Table 4: Frequency of infection
Frequency

Percentage

95
55
2
5
6
42

63.33
36.66
3.63
9.09
10.9
76.36

Absent
Present
Malaria
SBP
Gastroenteritis
Others (UTI, RTI)

Expire
100%

Cause

Grade of hepatic
encephalopathy

None
Single cause
Bleed
Infection
Constipation
Electrolyte Imbalance
More than 1 cause
Total

Total

II

III

IV

0

3

2

5

10

0
0
0
0
8
8

0
3
7
2
29
44

3
3
2
5
31
46

3
4
8
16
16
52

6
10
17
23
84
150

Spearman correlation: P value=0.012

Table 6: Relating outcome (mortality) with child
pugh class
Child-pugh class
Outcome
Discharge
Expire
Total

Total

B

C

9
0
9

53
11
64

45
32
77

7

80%
70%

34

60%
40%

8

42

39

30%
20%

18

10%
0%

I

A

2

90%

50%

Table 5: Relation between predisposing factors
& grade of hepatic encephalopathy

0

Discharge

107
43
150

Pearson’s R=0.022, Spearman correlation: P value=0.022

To assess the severity of liver disease in our patients,
Child-Pugh and MELD scoring systems were applied.
The mean MELD score of our patients was 17.2 while
mean Child-Pugh Score was 9.65.
Chi-square test was used to determine the relation of child’s
class with mortality rate, and it was found that mortality
rate was significantly high in child class C patients as shown
in Tables 6.
The grade of hepatic encephalopathy at the time of
presentation was directly related with the outcome
(P value < 0.001) and is summarized in the Figure 6.

DISCUSSION
A clearly defined precipitating factor is usually identified in
most patients with hepatic encephalopathy and the reversal
or control of these factors is a key step in the management.
The results of our study showed that 133 patients (88.66%)
were suffering from Hepatitis C, and 11 patients (7.33%)
Asian Journal of Medical Sciences | Mar-Apr 2015 | Vol 6 | Issue 2

Grade - Grade - Grade - Grade I
II
III
IV
Figure 6: Grade of hepatic encephalopathy relating with outome in
terms of mortality

were of hepatitis B. Since it was a consecutive type of
sampling, avoiding selection bias, so our findings are in
conformation with other studies, which also emphasize
the fact that HCV is a rapidly growing problem and has
already overtaken HBV in the etiogenesis of hepatic
encephalopathy in Pakistan.14,15 A review article by Jafri
described a rise in frequency of HCV as a cause of CLD
in Pakistan from 16.67% in early nineties to 51-86% over
a period of time.16
Constipation was the commonest factor responsible for
53% cases of Hepatic encephalopathy in our patients,
which is close to earlier published studies (as summarized
in Table 7),17-20 however contradictory with some of
national and international reports.21-28 High frequency of
constipation in our population was perhaps due to the
fact that people of our country were probably less aware
of the importance of constipation, precipitating hepatic
encephalopathy.19 Other factors responsible for prevalence
of constipation among our setup include dietary restriction,
poverty, lack of use or inappropriate dosing of lactulose
due to financial constrains, and lack of education regarding
role of diet in chornic liver disease.18,20 Also most of the
patient in our study belong middle age group, and that
increasing age effects the bowel habits, it may partly be the
reason of high prevalence of constipation in our study.21,22
Liver and brain biopsies were not taken in our study.
Proper guidance about a healthy diet which consists of
plenty of fresh fruits and vegetable, foods high in fiber
content (including whole-meal bread, whole-wheat cereal
and some raw bran in cereal or yoghurt), foods that are
high in Omega-3 fatty acids and adequate fluid intake to
avoid dehydration should be provided to all the patients
of Chronic liver disease. Exercise is an integral feature of
39
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Table 7: Comparison of our study with past literature (figures in percentages)
Author/Place/Year

Present Study/JPMC
Karachi/2013
Mahboob6
Bikha Ram Devrajani13/
LUMHS Jamshoro/2007
Akhtar Ali Baloch17/
CHK/2009
Naila Masood18/LUMHS
Jamshoro/2009
Hameed Ahmed19/
Lady Reading Hosp.
Peshawar
Saira Afzal20/KEMU
Lahore/2005-06
Col. Dr. Manzar
Zakaria21/CMH
Lahore/2007
Khalid Mumtaz22/AKUH
Karachi/2005-07
Dileep k. Rohra23/
CHK/2006
Intekhab Alam24/Lady
Reading Hospital
Peshawar/2005
Imran Ahmed25/CMH
Okara/2005
Souheil26
Faloon & Evans27
Conn & Liebertha28
M. Tariq32/Khyber
Teaching Hospital
Peshawar/2006

n

Constipation INF SBP Diarrhea Malaria

150

53

36.66 3.33

87

19
49

47
67

190

49.5

90

Other
GI Low Low Azotemia None 1 cause >1 cause
infections Bleed Na+ K+
(RTI, UTI)

12

1.33

28

34

54

34

52

6.66

37

56

-

5
-

-

-

30
45

-

33

-

6

-

-

38.9

-

-

-

-

32.6

-

-

-

-

-

-

31.1

27.8

-

-

-

-

10

-

13.3

-

-

50

52

-

-

22

-

-

56

28

68

-

-

-

-

50

60

10

-

-

-

-

18

-

-

-

-

-

-

80

6.3

27.5

-

-

-

-

56.3

-

-

-

8.8

-

-

404

18.3

-

20.5

-

-

15.3

13.6

3

6.4

-

-

53

35

256

12.1

-

10.9

-

-

9

15.2

-

-

-

50.8

-

-

50

32

24

-

40

-

-

22

38

18

-

-

-

-

43

20.9

7

-

-

-

-

37.2

-

14

-

9.3

-

-

100
39
1000
200

3
6
3
30

3
4
30

8

3

-

22

18
33
18
29

33
30
-

3
2
-

-

-

13.3 37.8

11
18
9
1.5 4.5

bowel management programs, and a lack of physical activity
is a factor in the development of constipation in some
people. Its effectiveness as an intervention to prevent or
treat constipation, however, has yet to be demonstrated.29

hypokalemia in our patients which was consistent with the
findings of Alam,24 but contradicts with those ofAhmed.19
Electrolyte imbalances also correlate with the severity of
the liver disease.33

Lactulose is a commonly prescribed agent to relieve
constipation in patients with chronic liver disease. It has an
added advantage as a non-absorbable disaccharide inhibiting
intestinal ammonia production by number of mechanisms.30,31

In our study, sedatives and Tranquilizers were not in use
of any patient, and the history taken from the attendants
and patients themselves were not suggestive of any self
prescription of such drugs. In this study the majority of
patients are in age group of 50 to 60 and the female were
dominant, which is contradictory with the findings observed
in a retrospective study, of hepatic encephalopathy in Saudi
Arabia34 and in civil hospital Hyderabad.13

Infections like SBP, urinary tract infection and lower respiratory
tract infection were the 2nd most common factor present in
37% of cases corresponds to the study of Mohammad Tariq
(2006).32 In West however the infection as a cause of hepatic
encephalopathy is not very common, possibly due to more
awareness and better nutrition status in their patients.
GI bleed was the third most important factor and was
found in 34% of patients in our study, which is similar to
30% found in Mehboob F (2003),6 although lower than
that reported by zakaria.21
Electrolyte imbalance was found in 29% patients. Among
electrolytes, hyponatremia was much more common than
40

When grading of encephalopathy is considered, in grade 3
and 4 electrolyte imbalance is the single most common
precipitating factor involved.
The mortality rate of hepatic encephalopathy is high as
shown by the study of Sargent et al35 whereas, in our study
the mortality was 29% and the majority were, Class C,
Child- Pugh classification. Patients with chronic HE are
known to have better long term (5 years) survival than those
who develop HE acutely (100% vs. 70% survival).36 But this
Asian Journal of Medical Sciences | Mar-Apr 2015 | Vol 6 | Issue 2
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survival can be improved as appropriate treatment and care
can cause complete recovery especially if encephalopathy
is elicited by a rescindable cause. So there is a definite
need for health education in patients regarding the risk
of HE and its precipitating factors, as lack of awareness
about this life threatening complication of CLD is itself a
cause of acquiring hepatic encephalopathy. So a constant
need and effort to obviate them by all possible measures is
necessary. Proper dietary advice must be an important part
of all counseling practices to chronic liver disease patients.

8.

Amodio P. The liver, the brain and nitrogen metabolism. Metab
Brain Dis 2009; 24: 1-4

9.

Mumtaz K, Ahmed US, Abid S, Baig N, Hamid S,
Jafri W. Precipitating Factors and The Outcome of Hepatic
Encephalopathy in Liver Cirrhosis.J Coll Physicians Surg
Pak 2010; 20(8):514-518.

10. Hahn M, Massen O, Nencki M, Pavlov I (1893). Die
Eck’schefistelzwischen der unterenhohlvene und der pfortader
und ihrefolgen fur den organismus. Arch Exp Pathol Pharm
32:161–210
11. Van Caulert C, Deviller C, Halff M (1932). Troubles
provoquesparl’ingestion
de
selsammoniacaux
chez
l’hommeatteint de cirrhose de Laennec. Comptes Rendus Soc
Biol 111:739–740.

CONCLUSION

12. Sthal J (1936). Studies of the blood ammonia in liver disease.
Ann Intern Med 58:1–24

Constipation is the commonest cause of hepatic
encephalopathy followed by infection, upper GI bleed
and electrolyte imbalance. Control of constipation is very
imperative in the avoidance of hepatic encephalopathy
in our setup. The leading cause of constipation is a
poor diet – poor choice of foods, or irregular eating. Patient
counseling is a key competency element in its prevention. In
most cases, simple changes in diet and lifestyle as described
above can help relieve symptoms and manage constipation,
and so very effectively prevent the development of this life
threatening complication of cirrhosis.

13. Devrajani BR, Shah SZ, Devrajani T, Kumar D. Precipitating
factors of hepatic encephalopathy at a tertiary care hospital
Jamshoro, Hyderabad. J Pak Med Assoc 2009; 59(10):683-686.
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